Dr. Michelle Sexton
Naturopathic Doctor
Phone:
6199405686
Email:
msexton@ucsd.edu
Type of Practice:
Integrative and Naturopathic Medicine

Education Associations

University of California San Diego (UCSD)

BASTYR UNIVERSITY 2008

Professional Associations

NATUROPATHIC MEDICINE ; American Association of Naturopathic Physicians, California Association of Naturopathic Physicians, International Cannabinoid Research Society, and International Association for Cannabinoid Medicine

Biography

Dr. Sexton is Assistant Adjunct Professor in the Department of Anesthesiology at the University of California San Diego. She is a Clinical Care provider at the Center for Integrative Medicine at UCSD, where she is the primary clinician at the first Cannabis Clinic established in an academic setting. She earned her Doctorate in Naturopathic Medicine from Bastyr University, Seattle Washington. She completed a postdoctoral fellowship at the University of Washington in the Departments of Pharmacology/Psychiatry and Behavioral Sciences, studying the endocannabinoid system and their roles in neuro-inflammation and neuro-degeneration. Her NIH-funded pre-doctoral and postdoctoral research investigated cannabis use in patients with Multiple Sclerosis and impact on inflammatory markers.

Dr. Sexton has presented her research internationally and published in peer-reviewed journals. Dr. Sexton’s clinical practice, research and teaching focus on the endocannabinoid system and potential roles for cannabis across a range of conditions and lifespan. She also maintains a private medical practice in San Diego, CA at The Pain Trauma Institute.

Publications

Sexton, M and Schuster, N “Medical Cannabis for Migraine and Pain”. Practical Neurology 2021

Sexton, M; Garcia, JM; Jatoi, A; Clark, CS; Wallace MS “The Management of Cancer Symptoms and Treatment-Induced Side Effects with Cannabis of Cannabinoids” Journal of the National Cancer Institute 2021; 58, p35-122

Sexton, M., Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. J Altern Complement Med, 2020. 26(6): p. 444-448.

Corroon, J; Sexton, M; Bradley R; “Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey” 2019 BMC Family Practice 20:174

Sexton, M; Cuttler, C; Mischley, LK “A Survey of Acute Effects of Cannabis and Withdrawal Symptoms: Differential Responses Across User Types and Age” Journal of Alternative and Complementary Medicine 2018 Oct 31 Open Access

Sexton, M; Shelton, K; Haley, P; West, M “Evaluation of Cannabinoid and terpenoid Content: Cannabis Flower Compared to Supercritical CO2 Concentrate” 2017 (accepted for publication) Planta Medica.

Sexton, M; Cuttler, C; Finnell, J; Mischley, LK “An International Survey of Medical Cannabis Use” 2016 Cannabis and Cannabinoid Research 1(1), pages131-138.

Sexton, M; Cudaback, E; Rehab, A; Finnell, J; Lichtman, A, Stella, N “Cannabis Use by Patients with Multiple Sclerosis: Effects on Some Immune Parameters” Inflammopharmacology: Volume 22, Issue 5 (2014), Page 295- 303

Cuttler, C.; Mischley, LK; Sexton, M “Sex Differences in Cannabis Use and Effects: A cross Sectional Survey of Cannabis Users” 2016 Cannabis and Cannabinoid Research 1(1), pages 166-175.

Sexton, M, Sylvestroni, A, Stella, N. “Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis” (2012) Inflammopharmacology, April 11.